SCHEMBL2324544

SCHEMBL2324544

CC(C)(C)C1CN(CC(F)(F)F)CCN1C(=O)O

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504744 0.81 KDM2B (0.30)
SCHEMBL2323287 0.80 HSD11B1 (0.31)
SCHEMBL2076961 0.79 MAPK1 (0.37)
SCHEMBL3572416 0.78 ALOX15 (0.36)
SCHEMBL21820340 0.78 P2RX7 (0.32)
SCHEMBL16099560 0.78
SCHEMBL1525497 0.77 CYP2J2 (0.33)
SCHEMBL1742800 0.77 BCHE (0.36)
SCHEMBL3657529 0.76 CYP2J2 (0.32)
SCHEMBL28780771 0.76 DRD3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356113-B1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER IP GMBH (DE) 2015-01-07 EP disclosed
EP-2356113-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-17 EP disclosed
WO-2010054763-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-20 WO disclosed